Carol A Vallone
CIK 1422058 · last filed 2026-09-18
Carol A Vallone is a corporate insider who has filed 11 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider exercised options covering $38.6K of DFTX on Sep 18, 2026. Across all open-market trades the lifetime net is +$1.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $715.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BNV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MANCHESTER, MA 01944
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DFTX | Director | 22,296 | $32.08 | $715.3K | $0 | 2 | 2026-09-18 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 16,544 | $15.00 | $248.2K | $0 | 5 | 2025-06-16 |
| BEVERLY NATIONAL CORP (BNV) Delisted | Director | 805 | — | — | $1.0K | 4 | 2009-11-02 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | DFTX | Exer (M) | +1,086 | $38.6K | EDGAR |
| 2026-06-15 | DFTX | Grant (A) | +4,666 | $0 | EDGAR |
| 2025-06-16 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +13,671 | $0 | EDGAR |
| 2022-06-06 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +43,104 | $0 | EDGAR |
| 2022-06-03 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +43,104 | $0 | EDGAR |
| 2009-11-02 | BEVERLY NATIONAL CORP (BNV) Delisted | Disp (D) | −485 | $0 | EDGAR |
| 2009-06-17 | BEVERLY NATIONAL CORP (BNV) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2008-04-01 | BEVERLY NATIONAL CORP (BNV) Delisted | Grant (A) | +135 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).